News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Videos|February 16, 2022

Coming Soon: Real-World Evidence in the Evolving Treatment Landscape of Multiple Myeloma

Author(s)Ryan Haumschild, PharmD, MS, MBA

Episodes in this series

multiple myeloma

EP. 1 Coming Soon: Real-World Evidence in the Evolving Treatment Landscape of Multiple Myeloma

EP. 2 A Multiple Myeloma Overview

EP. 2 A Multiple Myeloma Overview

EP. 3 MM and Regimens for First- and Second-Line Treatment

EP. 3 MM and Regimens for First- and Second-Line Treatment

EP. 4 MM From the Payers’ Perspective

EP. 4 MM From the Payers’ Perspective

EP. 5 MM Healthcare Resource Utilization

EP. 5 MM Healthcare Resource Utilization

EP. 6 Decision Support Tools for MM

EP. 6 Decision Support Tools for MM

EP. 7 MM and the Limitations of RCT Data

EP. 7 MM and the Limitations of RCT Data

EP. 8 MM and Real-World Evidence

EP. 8 MM and Real-World Evidence

EP. 9 The Value of RWE in MM

EP. 9 The Value of RWE in MM

EP. 10 Incorporating RWE in MM Decision-Making

EP. 10 Incorporating RWE in MM Decision-Making

EP. 11 RWE Decision-Making Barriers

EP. 11 RWE Decision-Making Barriers

EP. 12 MM and Non-Comparative RWE

EP. 12 MM and Non-Comparative RWE

EP. 13 Educating on RWE

EP. 13 Educating on RWE

EP. 14 MM Unmet Needs

EP. 14 MM Unmet Needs

EP. 15 Incorporating RWE Into Future Decision-Making

EP. 15 Incorporating RWE Into Future Decision-Making

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Dr Katherine Tobon

Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP

ByBrooke McCormick,Katherine Tobon, PharmD, BCOP

February 7th 2026

Even After 6 Years, Disease Progression Impacts Survival in Mantle Cell Lymphoma

February 6th 2026

Acalabrutinib | Image Credit: © Сергей Шиманович-stocka.dobe.com.jpeg

Real-World Evidence Backs Acalabrutinib in CLL Care

ByMaggie L. Shaw

February 6th 2026

Debates at the International Stroke Conference 2026 centered on optimal treatment of ischemic stroke in the modern era. | Image credit: Aliaksandr Marko - stock.adobe.com

Is Less More After Thrombolysis? Debating Intensive Stroke Monitoring at ISC 2026

February 6th 2026

Dr Susan Vadaparampil

Linking Community Screening Programs to Cancer Centers Boosts Trial Diversity: Susan Vadaparampil, PhD, MPH

ByBrooke McCormick,Susan Vadaparampil, PhD, MPH

February 6th 2026

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Trending on AJMC

As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”

TrumpRx Launch Brings Savings—and Uncertainty

Exploring Identity, Appearance Experiences Among Patients With Alopecia

Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP

Asundexian Reduces Risk of Stroke Recurrence in Phase 3 OCEANIC-STROKE Trial

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text